SETUP
-Preparation
-Priming
-Dearation level
-Starting treatment

ONGOING MANAGEMENT
-Preparation
-Priming
-Dearation level

SETUP IN CCTC

PREPARATION

• Before removing the set from the package, check all luer lock connections to ensure they are tight. In particular, check the access and return connections, the connections to all spikes and the connections at the dearation filter. Connections are loosely connected to facilitate gas sterilization.
• Prepare solutions. Remember to add KCl to dialysate per protocol. If dialysate is not being administered, KCl should be ordered to replacement solutions per protocol.
  • Standard CCTC Setup:
    • Predilution replacement administered via Pre Blood Pump (PBP)
    • Replacement pump programmed to deliver POST DILUTION replacement (usually at 200 ml/hr) to prevent clotting in the dearation chamber
  • Citrate Administration Only
    • Administer citrate via PBP
    • Administer all replacement fluid (e.g., 1000 ml/hr) POST DILUTION via replacement pump.
• Always turn the machine "OFF", then back "ON" before setting up a new filter (even if you restarting the same patient). This will ensure you have cleared any alarms from the previous run.
• Do not turn the heater on until after the circuit is connected to the patient and the heater tubing is filled with blood. When bicarbonate containing solutions are heated, CO2 gas is produced, increasing the number of bubbles.

SET PREPARATION

• Always setup in "CVVHDF" mode.
• Remember to connect the heater tubing.
  • Position the green marking on the heater tubing at the front of the heater and wrap from front to back.
  • Pull and stretch the tubing during positioning to reduce the chance of kinking when the cover is replaced.
  • Have a second person assist you as you open up the blue connection in the return tubing (below and to the left of the dearation chamber) and connect the heater tubing. There is only one way the heater tubing can be connected (male to female). It is normal for the return tubing to cross behind the filter and again underneath the heater.

PRIMING

• Be sure that the connections are tight, especially at the return protector (the filter above the dearation chamber), the access and return connections, and the luer lock connection on the spike inserted into the prime collection bag.
• If heparin is not being administered, prepare a 20 ml syringe with a LUER LOCK connection with 0.9 NaCl and install into the syringe pump.
• Hang a bag of normal saline on any pump that is not being used (e.g., if dialysate had not been ordered, hang saline on the dialysate pump during priming and set the dialysate flow rate at "0".
• In the last minute of priming, you can gently flick or wiggle the loop in the heater tubing to faciliate removal of air bubbles. Small air bubbles do not need to be removed.
• It is normal to have air in the effluent pod or a few inches of air in the effluent tubing. You DO NOT need to prime a second time; this air will be eliminated during the Prime Test.
• Air bubbles in the blood side will be collected in the dearation chamber.
• At the end of priming, check the dearation chamber and adjust the level if required.
  • Following priming, an air pocket will sometimes collect in the dearation chamber below the mesh filter, displacing fluid into the tubing above the dearation chamber.
  • Ensure that the
  • Always check the dearation chamber carefully; it can be difficult to differentiate fluid from air.
  • If fluid has risen into the tubing above the chamber, lower the fluid level by choosing "adjust level", and using the DOWN arrows to drop the fluid level below the dearation chamber. After the level is dropped, select the UP arrows and move the fluid level to the desired location.
  • It can be difficult to differentiate fluid from air. Dropping the level , appearing as though fluid is in the chamber.
  • DO NOT do any additional priming without hanging a second bag of priming solution or the bag will run dry during the prime test (the prime test using the remaining 150 ml of the 1 Litre bag of solution).

CONNECTING TO PATIENT

At the end of priming, select "continue" and enter flow rates prior to connecting the circuit to the patient.

Initate treatment with fluid removal set at "0" and blood flow rate at 150 ml/min.

Prior to connecting the circuit to the patient, switch the blue return line and the effluent line. (The effluent line should be moved to the effluent bag, and the return line should be moved to the "Y" connector on the priming "Y". Clamp the access and return lines and move the priming bag close to the patient's access site to facilitate connection.

Disconnect the access tubing from the "Y" connector and add a 3-way stopcock. Prime a regular IV tubing set with normal saline and connect to the stopcock.

Prepare the limbs (check for clots with a 3 cc syringe and flush with saline).

Instill the heparin bolus (if ordered) into the access limb and connect the stopcock at the end of the access line to the access limb.

Conect the return line to the return limb (blue to blue).

Do not manually prime without hanging a second bag of priming solution (use the same priming solution used for the first prime, e.g., add heparin if ordered). You will run out of saline during the Prime Test if you try to manually prime with the intial bag.

YOU MUST CONNECT THE PATIENT WITHIN 10 minute of priming. If more than 10 minutes elapses, repriming must be performed again.

ACCESS

Historically, early circuits removed blood from arterial access sites and returned the purified blood via a venous catheter. This promoted blood flow through the filter by utilizing the patients own arterial to venous blood pressure gradient.

Although arterial-to-venous access sites are still used in patients with end-stage renal failure, the blood flow pumps on modern hemodialysis machines eliminate the need for arterial-to-venous pressure gradients. Consequently, venous-to-venous circuits are often used. An example of an arterial-to-venous access site is a fistula. Fistulas are created surgically using graft material to connect a limb artery limb directly to a vein. They take several months to "mature" or dilate sufficiently to enable use of the fistula for dialysis access. Because they are under the skin, fistulas reduce the risk for bleeding and infection when long term therapy is required. Filter patency can be confirmed by listening with a stethoscope for a "bruit" (created by the rapid flow of blood though this large circuit) or by feeling a tingling sensation known as a "thrill". Never place a BP cuff or tourniquet above a fistula as this can reduce the flow through the circuit and lead to clotting.

Fistula	Double Lumen Venous Catheter

In critical care, temporary double lumen venous dialysis catheters are the most common form of access. They can be inserted quickly at the bedside and used immediately. "Perm" catheters are double lumen venous catheters that are designed for longer indwelling use. They are used more frequently in patients with chronic renal failure and may be used as a bridge until a surgically created fistula is ready for use.

Dialysis catheters are easy to differentiate from regular intravenous lines by their red and blue hubs. The red lumen denotes the side of the venous catheter that is used to pull blood from the patient, and is referred to as the access lumen. The blue lumen is the return site and is used to reinfuse the patient's blood after it passes through the dialysis filter. If an adequate flow rate cannot be achieved by removing blood from the access side of a catheter, the catheter limbs can be reversed. Reversal of the limbs does produce a small reduction in clearance due to recirculation.

Cautionary Note:
A double lumen venous dialysis catheter can technically be used as a central venous infusion site, however, to ensure the line remains patent for subsequent dialysis treatments, and to reduce the risk for infection, it is preferred that these catheters are used only for dialysis. If in a life-threatening situation it is the only vascular access available, it can be used as a central line, HOWEVER, it should always be assumed that the catheter contains heparin. The amount of heparin used to block the catheter limbs varies between dialysis programs. Typical concentrations are 5,000 - 10,000 units per mL. Because each lumen contains a volume of between 1.2 and 2 ml, limbs could contain up to 40,000 units of heparin! For this reason, ALWAYS assume that heparin is in the limb of any dialysis catheter. Always aspirate at least 5 mL of blood from EACH lumen prior to using the catheter.

Beginning April 1, 2005, we will begin using citrate solution to block all dialysis lines in CCTC (instead of heparin). Despite this change in practice, ALWAYS aspirate blood from both limbs before using a dialysis line for intravenous therapy.

PRINCIPLES

Hemodialysis employs the principles of diffusion, hemofiltration and convection, using an external filter to create an artificial nephron unit.

Recall the normal nephron unit:

A: Renal arteriole B: Afferent arteriole C: Efferent arteriole D: Bowman's Capsule E: Glomerulus F: Proximal Tubule G: Loop of Henle H: Distal Tubule I: Collecting Tubule

Diagrams: http://coe.fgcu.edu/faculty/greenep/kidney/nephron.htm

The diagram above depicts one nephron unit. Each kidney has approximately one million of these microscopic units. They collectively maintain water, electrolyte, waste and acid-base balance.

Arterial blood flows from the renal artery, branching into smaller divisions known as arterioles. Branches of the arterioles eventually carry blood into small "containers" called Bowman's Capsules, located in the cortex of the kidney. The arteriole that Arrives at the Bowman's Capsule is called the Afferent arteriole. The blood then flows into a specialized capillary (located inside the Bowman's Capsule), called the GLOMERULUS. Any blood remaining at the end of the glomerulus Exits the Bowman's Capsule via the Efferent arteriole.

The afferent arteriole is larger in diameter than the narrow efferent arteriole. This arrangement provides a high rate of blood flow into the glomerulus, but a high resistance to blood leaving the glomerulus. This structural difference from other capillaries ensures that the pressure within the glomerulus will be twice that of other capillaries. The increased glomerular pressure creates a hydrostatic force to promote filtration. The wall of the glomerulus is semi-permeable, allowing small and mid sized molecules to freely pass across the glomerular membrane and into the Bowman's Capsule. The increased hydrostatic pressure increases the movement of water across the membrane, dragging solutes or particles along in the process. The "washing" of solutes across the membrane with this large flux of water is known as convection. Because proteins are too large to fit across normal glomerular membranes, the protein remains in the blood and returns via the efferent arteriole. This prevents protein from appearing in the urine.

In order to eliminate all of the wastes that we want to remove, we have to filter very large volumes of water across the glomerulus. About 1200 ml per minute of filtrate is produced. By the time enough water has been moved across the membrane to wash out all of the surplus waste products, over-removal of water, glucose, electrolytes and other substances has occurred. Consequently, water and solutes must be reabsorbed from the filtrate in the tubules to maintain normal intravascular concentrations. Solutes and water are reabsorbed into capillaries that are wrapped around the tubules, called peritubular capillaries. The efferent arterioles become the peritubular capillaries, and are also responsible for perfusing the kidney. Surplus solutes can also be secreted into the tubules for elimination.

Reabsorption of needed water and solutes and secretion of surplus solutes continues along the renal tubules. The collecting tubule at the end of the tubule system contains the final filtrate. Any water or solute remaining in the collecting tubule is eliminated in the urine.

Artificial Kidneys

The dialysis filter is referred to as an artificial kidney. Blood is pulled from the patient and carried into the filter. Once inside, the blood travels through many tiny tubules called hollow fibers. Water and solutes can pass across the semi-permeable membrane between the blood and the fluid that surrounds the hollow fibers. Any fluid or solutes that enters the filter canister will be drained out as waste.

Schematic of dialysis filter (artificial kidney)

Note how the dialysis filter has structural similarities to the nephron unit. Blood arrives at the filter via the access tubing (afferent arteriole). Blood enters the small hollow fibers within the filter (glomerulus). Water and solutes diffuse across the semi-permeable membrane of the hollow fibers and collect in the canister (Bowman's Capsule). Collected fluid (filtrate or effluent) is then removed via the drainage tubing (collecting tubule). Blood that remains in the hollow fibers is returned to the patient via the return side of the filter (efferent arterial).

Although similarities exist between the nephron unit and the artificial kidney, the artificial kidney has limited capabilities. In the nephron unit, filtered water and waste enters the proximal tubule. Because the nephron unit removes significantly more water and solutes than needed, most of the water and electrolytes that enter the tubule system are reabsorbed.

Unlike the nephron unit, the artificial kidney cannot reabsorb water or solutes that enter the filter canister Any filtrate that enters the filter canister will be removed via the drainage tubule. Consequently, one of the differences in the artificial kidney is the absence of the proximal tubule, loop of henle and distal tubule where water and solute reabsorption and secretion occurs. Thus, the drainage tubule that exits the filter is similar to the collecting tubule of the nephron unit, not the proximal tubule. To compensate for the inability to reabsorb water and solutes following removal from the blood, the artificial kidney is manipulated to restrict the actual removal to only surplus water and wastes. This is done by adjusting dialysis solutions and ultrafiltration rates. If more water or solutes are removed than desired, they may need to be given back via intravenous infusions.

The artificial kidney does not replace other important kidney functions, including stimulation of red blood cell production (erythropoietin), blood pressure and sodium regulation (renin) and calcium uptake by the GI tract (vitamin D synthesis). The nephron normally traps and recycles bicarbonate to maintain acid base balance. Bicarb is given to patients during hemodialysis to compensate for bicarb deficits.

The principles used during hemodialysis are reviewed below:

DIFFUSION

Diffusion is the movement of particles (solutes) across a semi-permeable membrane. Diffusion is the movement from the side with the highest concentration of particles, to the side with the lowest concentration.

DIALYSIS FLUID (DIALYSATE):

Dialysate is the fluid that is pumped into the filter canister, surrounding the hollow fibers. The concentration of solutes in the dialysis fluid determines diffusion gradients. The removal of surplus solutes from the blood is achieved by infusing dialysate fluid that contains a lower solute concentration than the serum concentration (e.g. dialysate does not contain urea or creatinine).

To maintain normal serum electrolyte levels, dialysate fluid contains sodium, chloride and magnesium levels that are equal to serum concentrations (thus, removal of these electrolytes should only occur if the blood level exceeds normal serum concentrations). In renal failure, potassium is often high at the start of a treatment, therefore, we may begin dialysis with a low concentration of potassium in the dialysate. Because potassium is easily removed during dialysis, and continued dialysis will be required to ensure removal of other wastes such as urea and creatinine, potassium concentrations in the dialysate often require upward adjustment as the potassium level in the blood falls. Although in theory, potassium levels should not fall below 4 mmol/L in the serum if the dialysate contains 4 mmol/L, a number of factors influence serum potassium levels in critical care. Insulin therapy and the use of sympathomimetic drugs promotes the movement of potassium from the blood into the cells. This can lower serum levels. Additionally, potassium loss through the GI tract can increase the potential for hypokalemia. Low magnesium levels will also suppress the serum potassium levels, therefore, magnesium deficits should be replaced as needed. Additionally, high hemofiltration rates can lead to additional potassium clearance. Potassium levels must be monitored closely and adjusted to maintain normal serum concentrations.

In renal failure, serum bicarbonate levels are generally low, therefore, a source of bicarbonate is added to the dialysate to facilitate diffusion of bicarbonate into the blood. Lactate based formulas provide one source (e.g., Gambro's LG formulas). Higher concentrations of lactate in the dialysate promote diffusion into the blood. If hepatic function is normal, lactate is quickly converted to bicarbonate in the liver. Prisma(TM) and Prismaflex(TM) both use premixed bags of sterile dialysate. Lactate based preparations have a long stability, making them less expensive to prepare. Because bicarbonate is only stable for a short period in solution, it must be added to the dialysis bags before using.

If the patient is unable to convert lactate to bicarb at a rate that is fast enough, serum lactate levels will rise. This occurs in both hepatic insufficiency and shock states were the patient already has excess lactate production due to anaerobic metabolism. In these instances, a bicarb containing product is used to deliver bicarbonate (e.g. B.O or Normocarb).

If 1 L of dialysate is administered per hour, one L of dialysate fluid will collect in the drainage collection bag per hour. This will be in addition to any fluid removed; dialysate doesn't normally cross into the bloodstream.

Concentration gradients play a major role in diffusion. These will be explored further in the discussion on clearance. The other factor that influences diffusion is the type of filter used. Diffusion of solutes cannot occur across a concentration gradient if the pore size is too small to permit passage.

ULTRAFILTRATION

Ultrafiltration is the movement of water across a semi-permeable membrane because of a pressure gradient (hydrostatic, osmotic or oncotic). The increased blood pressure in the glomerulus creates a favourable driving pressure to force water across the glomerular membrane.

Blood pressure within the hollow fibers is positive, while the pressure outside the hollow fibers is lower. Increased negativity can be generated outside the hollow fibers by the effluent pump by either increasing the fluid removal rate, or by increasing the replacement flow rate. The difference between the blood pressure in the hollow fibers and the surrounding pressure is the TransMembrane Pressure (TMP). The TMP determines the ultrafiltrate production.

Different filter membrane properties can produce different ultrafiltration rates at a constant TMP. A filter that is more permeable to water will allow more water to travel across the membrane at a given TMP. A filter with a high permeability to water is called a high flux membrane.

HEMOFILTRATION

In hemodialysis circuits, pulling large volumes of water across the semi-permeable membrane creates a convective current that "drags" additional solutes. While diffusion is effective at removing most small molecules, convection enhances the removal of small and mid-sized molecules. Thus, convection can be added to hemodialysis therapy to enhance solute removal. To prevent hypovolemia, any water removed during hemofiltration must be returned to the blood before it reaches the patient. This is called "replacement" fluid. Hemofiltration rates of 1 L/hr mean that one liter of fluid is removed from the patient's blood and eliminated in the drainage fluid AND 1 L of replacement fluid is returned to the circuit before it reaches the patient. We set hemofiltration rates by adjusting replacement rates. Any fluid removed during hemofiltration is given back to maintain a net neutral fluid balance. Replacement fluid must be sterile intravenous fluids with concentrations of electrolytes similar to plasma.

For example, if the CRRT therapy includes a hemofiltration rate of 1 L per hour, and the fluid removal is set at 200 ml per hour, 1200 ml will be pulled from the patient and introduced into the drainage collection bag each hour. Because the 1 L of hemofiltration is replaced, the net fluid removed is 200 ml. Whether hemofiltration is used or not, the net fluid removed is equal to the fluid removal setting.

PREDILUTION VERSUS POSTDILUTION HEMOFILTRATION

Replacement fluids can be returned either pre or post filter. This is referred to as predilution or post dilution sets. Predilution means that the replacement solution is returned to the blood before it reaches the filter, diluting the blood in the hollow fibers. Postdilution means that the replacement fluid is returned to the blood after the filter (but before the return side of the access catheter). Predilution dilutes the blood in the filter, reducing clotting. Postdilution concentrates the blood in the filter, enhancing clearance.

CLEARANCE

Creatinine is a byproduct of muscle protein metabolism that is completely filtered by the glomerulus and 100% eliminated. None of the filtered creatinine is reabsorbed from the tubules nor is any additional creatinine secreted into the tubule lumen post glomerulus. This makes it the best indicator of renal failure. Because it is completely eliminated during normal renal function, measurement of creatinine clearance is the best measure of glomerular filtration.

Urea is another byproduct of protein metabolism, however, it is a byproduct of all protein metabolism (not just muscle protein metabolism). It is filtered into the glomerular filtrate. Unlike creatinine, a percentage of filtered urea is reabsorbed from the tubules. Consequently, urea levels can become increased in the presence of a normal creatinine level. For example, urea can increase due to increased urea production (e.g., anabolic or catabolic states) or increased tubule reabsorption of urea (e.g., due to dehydration). Creatinine only increases when renal filtration decreases, or the production of creatinine becomes so high that it exceeds glomerular filtration capabilities. Excessive creatinine production can occur when significant muscle death has occurred, for example in rhabdomyolysis.

Clearance is the rate at which solutes are cleared from the body. Clearance is abbreviated by the letter K. The clearance (or K) of a solute is the volume of blood from which the substance is completely removed per unit time (Gambro training manual). It is calculated as follows:

K = excretion rate of solute / blood concentration of solute

To translate this to dialysis: if a dialyzer has the ability to clear 170 ml/min of urea at a blood flow rate of 200 ml/min, it means that for every 200 ml of blood that flows through the filter, 170 ml will be returned urea free. The remaining 30 ml will have the same concentration of urea as the blood entering the filter. The 200 ml of blood being returned each minute to the systemic circuit will have significantly less urea than without dialysis, but will still have to mix in with the systemic volume. Thus, blood must continually circulate through the filter before the total systemic level will begin to fall.

The following formula can be used to calculate the clearance of a solute in ml/min at the dialysis membrane. To calculate the rate of clearance of a solute, the following formula can be used, where Q(blood)in is the flow of blood into the filter, Q(blood)out is the flow of blood out of the filter, C(blood)in is the concentration of the solute in the prefilter serum and C(blood) is the concentration of the solute in the post filter blood. Q(blood)in and Q(blood)out are the same and equal to the blood flow rate.

This can be simplified to:

Example below: At a blood flow rate of 150 ml/min, with a prefilter creatinine of .980 and post filter concentration of .343, the creatinine clearance by the filter is 97.5 ml/min. This assumes that no hemofiltration is being used.

FILTERS

Dialysis membranes need to be efficient at clearing wastes, but must also be biocompatible with human blood. Compatibility means that exposure of blood to the dialysis membrane produces minimal of adverse effects.

Filter permeability is influenced by pore size, the number of pores and the thickness of the membrane. Generally, high flux membranes which have more or larger pores allow more solutes and ultrafitrate to move across the membrane. Thinner membranes offer less resistance to solute movement by decreasing the distance the solute must travel across the membrane and also favours increased filtration.

Solutes are pass through the membrane according to solute size. Imagine taking a flour sieve and filling it with a mixture of sand, small rocks and debris. Shaking up the contents would cause the smallest particles to move towards the bottom, passing through the openings easily. Particles would be filtered through according to increasing size until you are left with particles to large to fit through the sieve. Dialysis membranes act the same way, allowing small and mid sized molecules to pass across the membrane, without the loss of larger proteins. High flux membranes that have a larger pore size increase clearance by allowing larger molecules to pass through the membrane, and by allowing more ultrafiltrate flow. The standard AN69 filter used with CRRT is a high flux membrane. Sieving properties of a membrane describe the membrane's permeability to solutes during ultrafiltration. Permeability of solutes decrease as the the molecular size increases. The cut-off point for a membrane is defined by the molecular weight where only 10% of the solute is filtered.

The surface area of the membrane determines the available area for diffusion and ultrafiltration. The internal volume of the dialysis filter should be small enough to limit the amount of blood that is outside of the vascular compartment at any given time. This volume is important if the filter clots before blood can be returned to the patient.

Finally, adsorption is the ability of larger solutes to adhere to the surface of the dialysis membrane. AN69 filters used in CRRT have strong adsorptive properties. Adsorption of mid sized molecules including inflammatory mediators have been demonstrated by a drop in serum concentrations following initiation of a new filter. The greatest benefit appears to occur in the first few hours; once the filter becomes saturated with proteins, further removal from the serum is limited. While these proteins are too large to pass through the filter and be removed in the filtrate, the removes the cytokines from the blood by allowing the to collect (like a sponge) in the filter.

TMP is the pressure exerted on the dialysis membrane during operation and reflects the difference between blood and fluid compartments. A TMP above +350 mmHg will produe an advisory alarm. A TMP > 450 will produce a "TMP excessive" alarm. The amount of increase and the rate of TMP increase contribute to the "Filter is Clotting" alarm.

Filter Pressure drop is another indicator of clotting. It is an indication of the pressures in the hollow fibers of the filter. It will slowly rise with filter use as the hollow fibers become filled with microscopic clot. The amount and rate of increase determines the activation of the "filter is clotting alarm".

DIFFUSION

Small molecular weight solutes are easily removed by diffusion (dialysis). The higher the concentration gradient, the higher the diffusion rate. Solutes will move across a semipermeable membrane until the two solute concentrations become equal.

As solutes move into the dialysate fluid, the dialysate concentration of the solutes increase, reducing the diffusion gradient. Once the dialysate concentration of a solute becomes equal to the blood concentration, diffusion stops. To maintain a high diffusion gradient, the difference between the blood and dialysate concentrations must be maintained. Clearance can be increased by higher dialysate or blood flow rates. Increasing the dialysate rate maintains a low concentration of solutes on the dialysate side by increasing their removal from the dialysate fluid. Increasing the blood flow rate brings more solutes to the filter, promoting continuous diffusion. The smaller the molecule, the greater the clearance by dialysate/blood flow increases.

Although higher blood flow rates will increase the rate of clearance, CRRT circuits have limitations. The smaller filter size (compared to hemodialysis circuits) limits the blood flow rates. Blood flows can be increased substantially with hemodialysis, however, blood flow rate adjustments are limited with CRRT.

While increased dialysate flow rates enhance the clearance of small molecules, middle sized molecule clearance is more dependent upon the size of the filter pores. The only way to increase the clearance of middle sized molecules is to add convection (hemofiltration).

Optimal solute clearance is produced when dialysate flow rates are approximately double that of the blood flow rates. CRRT blood flow rates are typically 150 ml/min. A dialysate flow rate of 1 L per hour, provides a dialysate flow of 16 ml/min. Increasing the dialysate flow will have a greater effect than any increase in blood flow rates with CRRT.

Dialysate flows countercurrent, or in the opposite direction to blood flow. This promotes continual clearance by ensuring an adequate diffusion gradient is maintained. Dialysate fluid is introduced at the return end of the filter, where the serum concentration of solutes has begun to fall (due to removal from the blood within the filter). The dialysate fluid flows towards the access end of the filter where the fluid drainage tubing is located. Diffusion of solutes along the filter makes the concentration of wastes highest in the dialysate at the access end of the filter. At the access end, the blood concentration of the solute is highest , counterbalancing the rising dialysate concentration.

HEMOFILTRATION

Dialysis effectively removes small (e.g. electrolytes) and small to mid size molecular weight solutes (e.g. glucose, urea, creatinine). The pore size limits the ability to diffuse middle sized molecules. One way to increase the clearance of all small and more of the mid sized molecules is to pull large quantities of water across the semi-permeable membrane, “dragging” additional solutes by convection.

Higher hemofiltration rates are of interest in critical care. Higher pre dilution rates may be a successful alternative to anticoagulant therapy, although, research is needed to examine this option. There is also interest in the potential clearance of mid sized molecular weight solutes including inflammatory mediators. In a European trial, hemofiltration rates of 35 ml/kg/hr were associated with the best survival rates. Although higher hemofiltration rates have been used in CCTC, our current practice uses predilution therapies. In this trial by Ronco, post dilution was used. The significance of high hemofiltration rates using predilution replacement is not known.

While increased ultrafiltration rates during hemofiltration help to remove molecules too large to travel by diffusion, hemofiltration can also lead to excessive removal of small molecules. Consequently, electrolyte removal can be increased beyond that produced by the diffusion gradient alone (e.g., despite a dialysate concentration of sodium that is equal to normal serum levels, sodium levels can fall with high hemofiltration rates).

Alternatively, high infusion rates of replacement fluids containing 0.9 NaCl can lead to hypernatremia. It can also increase chloride levels leading to hyperchloremic acidosis (chloride and bicarbonate are both negatively charged, increased chloride levels can cause a decrease in bicarbonate to maintain anionic balance).

When hemofiltration rates are high, careful monitoring is required to maintain normal electrolyte balance. Replacement fluids may need to be adjusted to keep serum levels within range. Alternatively, intermittent boluses of electrolytes may be required.

THERAPIES

Original continuous hemodialysis circuits required arterial to venous access sites, because they did not utilize a blood pump to pull blood through the filter. Consequently, they were referred to as CAV (Continuous arterial-venous) circuits. Today's technology uses a blood flow pump, therefore, most continuous circuits are CVV (continuous venous-venous).

SCUF (Slow Continuous Ultrafiltration):
SCUF is the removal of water from the patient's blood as it travels through the filter. Water removal is referred to as ultrafiltration. SCUF is a therapy designed to only remove surplus water. The amount of water removed is not sufficient to remove wastes.

CVVH (Continuous Venous-Venous Hemofiltration)
CVVH is the removal of large amounts of water across the filter membrane for the purpose of clearing wastes. When large volumes of water are washed across the membrane, solutes are dragged along with the water (convection). Hemofiltration is the removal of water over and above the surplus water removed during ultrafiltration. To prevent hypovolemia, water removed during hemofiltration must be given back before the blood is returned to the patient. This is referred to as replacement. CVVH is the use of replacement fluid without dialysis fluid, plus or minus fluid removal.

CVVHD (Continuous Venous-Venous Hemodialysis):
CVVHD is the infusion of dialysis fluid into the filter canister The dialysis fluid (dialysate) surrounds the blood filled filter segments. Solutes that are small enough to fit through the membrane of the dialysis filter will move from an area of high concentration to low concentration (diffusion). The dialysate determines the solutes that will be removed. If we want to remove solutes, the concentration in the dialysate is lower than the blood concentration. If we want to give something to the patient, the concentration in the dialysate is higher than the blood. CVVHD is the removal of wastes by diffusion only, without the use of hemofiltration (replacement fluid). It can be administered with or without fluid removal from the patient.

CVVHDF (Continuous Venous-Venous HemoDiaFiltration):
CVVHDF is the use of dialysis AND hemofiltration. Therapy will include the use of both dialysate and replacement fluids and can be administered with or without fluid removal from the patient.

Return to top

References:
Gambro Training Manual 1 and 2
Slides from Gambro Training package, reproduced with permission

Last Update: March 30, 2010.